Status: Not yet recruiting
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
Clinical trials of IBI3040 with single-dose administration in healthy participants and multiple-dose administration in overweight or obese participants.
Participants needed: 96
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Innovent Biologics (Suzhou) Co. Ltd.Updated: Aug 14, 2026Locations: 1
Eligibility criteria
1.The age at the time of informed consent should be between 18 and 65 years old... [+7]
1.Participants may be allergic to any component of the investigational drug, GLP... [+23]